Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the 10 Best Penny Stocks to Buy Before They Explode. On May 7 ...
GAAP net loss for the first quarter of 2026 was $8.3 million, compared to $426.1 million for the first quarter of 2025. Non-GAAP net loss for the first quarter of 2026 was $35.9 million, compared to ...
PacBio (PACB) stock drops 16% after a Q1 revenue miss and margin pressure; full-year 2026 revenue guidance narrowed below estimates.
StockStory.org on MSN
PacBio (NASDAQ:PACB) misses Q1 CY2026 sales expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q1 CY2026, with sales flat year on year at $37.18 million ...
Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 14.2% in the afternoon session after the ...
Q1 2026 Management view "Our first quarter of 2026 was highlighted by record consumable revenue, greater than 100% year-over-year growth in consumable shipments to clinically focused accounts and ...
HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif., March 12, 2024 /PRNewswire/ -- PacBio (PACB) (NASDAQ: PACB), a ...
The HiFi Solves Sub-fertility Consortium in Asia Pacific was launched at PRISM Asia 2024 to advance long-read sequencing in reproductive genomics. Its first major findings will now be presented at ...
Personal Genomics Taiwan Inc. and Pacific Biosciences of California Inc. settled a case Personal Genomics launched more than six years ago alleging PacBio’s Sequel system infringes a genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results